Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline in the treatment of obsessive-compulsive disorder
IRCT201501031556N70Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of minocycline in obsessive compulsive disorder (OCD), sponsored by Tehran University of Medical Sciences. Started Jan 2015; status: completed.
02
Drugs
minocycline
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on IRCT201501031556N70.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201501031556N70.